CAFEX
Price
$45.09
Change
+$0.10 (+0.22%)
Updated
Dec 3 closing price
Net Assets
97.32B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

CAFEX vs VIGRX

Header iconCAFEX vs VIGRX Comparison
Open Charts CAFEX vs VIGRXBanner chart's image
American Funds AMCAP 529E
Price$45.09
Change+$0.10 (+0.22%)
VolumeN/A
Net Assets97.32B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
CAFEX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
CAFEX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAFEX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. CAFEX (97.3B). VIGRX pays higher dividends than CAFEX: VIGRX (0.30) vs CAFEX (0.14). CAFEX was incepted earlier than VIGRX: CAFEX (24 years) vs VIGRX (33 years). CAFEX (0.91) is less costly to investors than VIGRX (0.17). CAFEX is a more actively managed with annual turnover of: 36.00 vs. VIGRX (11.00). CAFEX has a lower initial minimum investment than VIGRX: CAFEX (250) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. CAFEX (3.53). VIGRX return over 5 years is better than : 99.11 vs. CAFEX (20.67).
CAFEXVIGRXCAFEX / VIGRX
Total Expense Ratio0.910.17535%
Annual Report Gross Expense Ratio0.910.17535%
Fund Existence24 years33 years-
Gain YTD12.50019.76463%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets97.3B357B27%
Annual Yield % from dividends0.140.3046%
Returns for 1 year3.5318.4919%
Returns for 3 years51.02110.8246%
Returns for 5 years20.6799.1121%
Returns for 10 years68.51349.1320%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT